Global Radiofrequency Ablation Devices Market for Oncology Management: Overview 

Radiofrequency ablation for cancer is a minimally invasive surgical procedure that involves a local anesthetic and mild selection. In the procedure, electric energy and heat is passed through a specialized needle to destroy cancer cells with the help of an image-guided technique such as CT, MRI, etc.. Radiofrequency ablation is mostly used to treat a spot of cancer that is causing problems such as pain. Radiofrequency ablation treatment is generally not used as the primary treatment for cancer. Radiofrequency ablation treatment options are very effective for patients who might have difficulty with surgery or those whose tumors are less than five inches in diameter. Radiofrequency ablation is often done on an outpatient basis. The best advantage of this procedure is that more than half of the liver tumors treated by ablation have not recurred. 

Global Radiofrequency Ablation Devices Market for Oncology Management: Key Trends

Increase in the prevalence of cancer, growing adoption of radiofrequency ablation for pain management in oncology patients, favorable regulatory scenario, and health care reforms are some factors that boost the demand for radiofrequency ablation devices for oncology management. However, availability of pain management therapeutics such as NSAIDs and opioids at low cost for cancer patients is expected to hamper the market.     

Global Radiofrequency Ablation Devices Market for Oncology Management: Segmentation 

The global radiofrequency ablation devices market for oncology management can be segmented based on product, cancer, end-user, and region. Based on product, the global radiofrequency ablation devices market for oncology management can be classified into needle electrodes, electric generator, grounding pads, and others. The needle electrodes segment can be further classified into simple straight needles and hollow needles. The electric generator system segment is projected to account for a significant share of the market during the forecast period. Technological advancements such as cooled radiofrequency technology platforms that allow the creation of larger lesions without excessive heating at the electrode fuel the growth of the segment. In term of cancer, the global radiofrequency ablation devices market for oncology management can be classified into liver cancer, colon cancer, lung cancer, and others. The liver cancer segment is expected to dominate the market, owing to the wide use of radiofrequency ablation devices in the treatment of tumors that are generally less than five inches and widely occur mostly in the liver. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment is expected to expand at a high CAGR during the forecast period, owing to high preference of patients to get all types of treatments under one roof. 

Global Radiofrequency Ablation Devices Market for Oncology Management: Regional Analysis 

In terms of region, the global radiofrequency ablation devices market for oncology management can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018. The region is projected to account for a significant share of the global market due to the availability of well-defined reimbursement policies from public and private health insurance firms, which helps patients to easily access of surgery. Asia Pacific is expected to consititute a substantial share of the market, in terms of revenue, during the forecast period. This is due to the emergence of the region as a major manufacturing hub and rise in expertise and academic excellence in the region.

 

Global Radiofrequency Ablation Devices Market for Oncology Management: Competitive Landscape 

Major players operating in the global radiofrequency ablation devices market for oncology management include Abbott, AngioDynamics, Inc., Boston Scientific Corporation, Diros Technology, Inc., Medtronic, Merit Medical System, Inc., and ArtiCure, Inc..

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.